Feasibility of a day clinic for integrative prehabilitation complementary to neoadjuvant cancer treatment – PRIME-DC
- Conditions
- C17C18C19C20C21C22C23C25C67C61
- Registration Number
- DRKS00028126
- Lead Sponsor
- niversitätsklinikum Ulm
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 23
1. Patients diagnosed with intracavity cancer (including extraperitoneal cancers like prostata, bladder, rectal or esophageal cancer) and breast cancer
2. Patients planned to undergo or undergoing neoadjuvant treatment
3. Planned potentially curative oncological setting
4. Adult Patients (= 18 years of age)
5. Written informed consent
6. Ability to understand character and individual consequences of the clinical trial
7. Investigator considers patient suitable for day clinic program
1. Participation in another interventional trial with interference on intervention and outcome of this trial
2. American Society of Anesthesiologists (ASA) grade >3
3. Immobility or inability to walk unaided
4. Expected lack of compliance
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility endpoints:<br>1. Recruitment of a minimum of 8 patients within 3 months.<br>2. Compliance defined as 80% of participants attending a minimum of 7 out of 11 day clinic sessions.
- Secondary Outcome Measures
Name Time Method